BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29278730)

  • 1. CM-viewer: Visualizing interaction network of co-mutated and mutually exclusively mutated cancer genes.
    Zhou N; Hu Z; Wu C; Bao J
    Biosystems; 2018 Apr; 166():37-42. PubMed ID: 29278730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Epistasis in Cancer Genomes: A Delicate Affair.
    van de Haar J; Canisius S; Yu MK; Voest EE; Wessels LFA; Ideker T
    Cell; 2019 May; 177(6):1375-1383. PubMed ID: 31150618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis.
    Remy E; Rebouissou S; Chaouiya C; Zinovyev A; Radvanyi F; Calzone L
    Cancer Res; 2015 Oct; 75(19):4042-52. PubMed ID: 26238783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
    Zhang J; Zhang S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared and unique mutational gene co-occurrences in cancers.
    Liu J; Zhao D; Fan R
    Biochem Biophys Res Commun; 2015 Oct; 465(4):777-83. PubMed ID: 26315265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.
    Wang J; Zhang Y; Shen X; Zhu J; Zhang L; Zou J; Guo Z
    Mol Biosyst; 2011 Apr; 7(4):1158-66. PubMed ID: 21279201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence.
    Canisius S; Martens JW; Wessels LF
    Genome Biol; 2016 Dec; 17(1):261. PubMed ID: 27986087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic heterogeneity of driver gene mutations reveals novel mutual exclusivity and improves exploration of functional associations.
    Lan Y; Liu W; Zhang W; Hu J; Zhu X; Wan L; A S; Ping Y; Xiao Y
    Cancer Med; 2021 Jul; 10(14):4977-4993. PubMed ID: 34076361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Combinatorial Mutational Patterns in Human Cancer Genomes by Exclusivity Analysis.
    Tan H; Zhou X
    Methods Mol Biol; 2018; 1711():3-11. PubMed ID: 29344882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial patterns of somatic gene mutations in cancer.
    Yeang CH; McCormick F; Levine A
    FASEB J; 2008 Aug; 22(8):2605-22. PubMed ID: 18434431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us.
    El Tekle G; Bernasocchi T; Unni AM; Bertoni F; Rossi D; Rubin MA; Theurillat JP
    Trends Cancer; 2021 Sep; 7(9):823-836. PubMed ID: 34031014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of driver pathways using mutated gene network in cancer.
    Li F; Gao L; Ma X; Yang X
    Mol Biosyst; 2016 Jun; 12(7):2135-41. PubMed ID: 27118146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BeWith: A Between-Within method to discover relationships between cancer modules via integrated analysis of mutual exclusivity, co-occurrence and functional interactions.
    Dao P; Kim YA; Wojtowicz D; Madan S; Sharan R; Przytycka TM
    PLoS Comput Biol; 2017 Oct; 13(10):e1005695. PubMed ID: 29023534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.
    Leiserson MD; Vandin F; Wu HT; Dobson JR; Eldridge JV; Thomas JL; Papoutsaki A; Kim Y; Niu B; McLellan M; Lawrence MS; Gonzalez-Perez A; Tamborero D; Cheng Y; Ryslik GA; Lopez-Bigas N; Getz G; Ding L; Raphael BJ
    Nat Genet; 2015 Feb; 47(2):106-14. PubMed ID: 25501392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of mutated subnetworks associated with clinical data in cancer.
    Vandin F; Clay P; Upfal E; Raphael BJ
    Pac Symp Biocomput; 2012; ():55-66. PubMed ID: 22174262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An information theoretic method to identify combinations of genomic alterations that promote glioblastoma.
    Melamed RD; Wang J; Iavarone A; Rabadan R
    J Mol Cell Biol; 2015 Jun; 7(3):203-13. PubMed ID: 25941339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Gene Discovery by Network Analysis of Somatic Mutations Using the MUFFINN Server.
    Han H; Lehner B; Lee I
    Methods Mol Biol; 2019; 1907():37-50. PubMed ID: 30542989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ccmGDB: a database for cancer cell metabolism genes.
    Kim P; Cheng F; Zhao J; Zhao Z
    Nucleic Acids Res; 2016 Jan; 44(D1):D959-68. PubMed ID: 26519468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity.
    Tan H; Bao J; Zhou X
    Sci Rep; 2015 Jul; 5():12566. PubMed ID: 26212640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.